The pharmacokinetics and tissue residue of tylosin in broiler chickens were studied after I.V. and oral administrations in a dose of 50 mg tylosin/kg.b.wt. Tylosin was obeyed a two-compartment open model following I.V. administration at a dose of 50 mg/kg.b.wt. The disposition kinetics of tylosin following I.V. administration revealed that tylosin was highly distributed with Vd(area) of 6 L/kg and eliminated with half-life (t1/2β) equal to 7.29 hours. The disposition kinetics of tylosin following oral administration revealed that the maximum blood concentration (Cmax) was 3.40 μg/ml attained at (tmax) of 1.08 hour. Tylosin was eliminated with half-life (t1/2β) equal to 5.78 hours. The mean systemic bioavailability of tylosin after oral administration was 90.29%. Following repeated oral administration of 50 mg tylosin base/kg.b.wt once daily for 5 consecutive days, the blood (μg/ml) and tissue (μg/g) residues of tylosin showed that liver, kidney and lung contained the highest tylosin residues and completely disappeared from those tissues at 6 days after the last oral dose. Chickens should not be slaughtered for human consumption within the treatment and 6 days after the last oral administrations of tylosin.
References
[1]
Furusawa, N. (1999) Spiramycin, Oxytetracycline and Sulphamono-Methoxine Contents of Eggs and Egg-Forming Tissues of Laying Hens. Journal of Veterinary Medicine Series A, 46, 599-603. http://dx.doi.org/10.1046/j.1439-0442.1999.00247.x
[2]
Kowalski, C., Rolinski, Z., Zan, R. and Wawron, W. (2002) Pharmacokinetics of Tylosin in Broiler Chickens. Polish Journal of Veterinary Science, 5, 127-130.
[3]
Scott, P.R., McGowan, M., Sargison, N.D., Penny, C.D. and Lowman, B.G. (1996) Use of Tilmicosin in a Severe Out-break of Respiratory Disease in Weaned Beef Calves. Australian Veterinary Journal, 73, 62-64. http://dx.doi.org/10.1111/j.1751-0813.1996.tb09967.x
[4]
Stark, W.M., Daily, W.A. and McGuire, J.M. (1961) A Fermentation Study of the Biosynthesis of Tylosin in Synthetic Media. Scientific Report of the Istituto Superiore di Sanita, 1, 340-354.
[5]
Giguere, S. (2006) Lincosamindes, Macrolides, and Pleuromutilins. In: Antimicrobial Therapy in Veterinary Medicine, 4th Edition, Wiley Blackwell, Ames, 179-190.
[6]
Montesissa, C., DeLiguoro, M., Santi, A., Capolongo, F. and Biancotto, G. (1999) Tylosin Depletion in Edible Tissues of Turkeys. Food Additives and Contaminants, 16, 405-410. http://dx.doi.org/10.1080/026520399283795
[7]
Kong, K., Yuan, Z., Fan, S., Wang, D., Qin, I.T., Zhou, S., Yang, E. and Cai, J. (1999) HPLC Analysis of Erythromycin Residues in Broiler Tissues. Chinese Journal of Veterinary Science, 19, 489-491.
[8]
Musser, J., Mechor, G.D., Grohn, Y.T., Dubovi, E.J. and Shin, S. (1996) Comparison of Tilmicosin with Long-Acting Oxytetracyline for Treatment of Respiratory Tract Disease in Calves. Journal of the American Veterinary Medical Association, 208, 102-106.
[9]
Gaynor, M. and Mankin, A.S. (2005) Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance. Frontiers in Medicinal Chemistry, 2, 21-35. http://dx.doi.org/10.2174/1567204052931113
Carbon, C. (1998) Pharmcodynamics of Macrolides, Azalides, and Streptogramins: Effect on Extracellular Pathogens. Clinical Infectious Disease, 27, 28-32. http://cid.oxfordjournals.org/content/27/1/28.full.pdf http://dx.doi.org/10.1086/514619
[12]
Arret, B., Johnson, D.P. and Kirshbaum, A. (1971) Outline of Details for Microbiological Assay of Antibiotics. 2nd Revision. Journal of Pharmaceutical Sciences, 60, 1689-1694. http://dx.doi.org/10.1002/jps.2600601122
[13]
Tsai, G.E. and Kondo, F. (2001) Improved Agar Diffusion Method for Detecting Residual Antimicrobial Agents. Journal of Food Protection, 64, 361-366.
[14]
Yoshida, M., Kubota, D., Yonezawa, S., Nakamura, H., Azechi, H. and Terakado, N. (1971) Transfer of Dietary Spiramycin into the Eggs and Its Residue in the Liver of Laying Hen. Japan Poultry Science, 8, 103-110. https://www.jstage.jst.go.jp/article/jpsa1964/8/2/8_2_103/_pdf http://dx.doi.org/10.2141/jpsa.8.103
[15]
Yoshida, M., Kubota, D., Yonezawa, S., Nakamura, H., Yamaoka, R. and Yoshimura, H. (1973) Transfer of Dietary Erythromycin into the Eggs and Its Residue in the Liver of Laying Hen. Japan Poultry Science, 10, 29-36. http://dx.doi.org/10.2141/jpsa.10.29
[16]
Roudaut, B., Moretain, J.P. and Biosseau, J. (1987) Excretion of Oxytetracycline in Egg after Medication of Laying Hens. Food Additives and Contaminants, 4, 297-307. http://dx.doi.org/10.2141/jpsa.10.29
[17]
Roudaut, B. and Moretain, J.P. (1990) Residues of Macrolide Antibiotics in Eggs Following Medication of Laying Hens. British Poultry Science, 31, 661-675. http://dx.doi.org/10.1080/00071669008417297
[18]
Yashimura, M., Osawa, D., Rasa, F.C.S., Hermawati, D., Werdiningsihi, S., Isriyanthi, N.M.R. and Sugimoto, T. (1991) Residues of Doxycycline and Oxytetracycline in Eggs after Medication via Drinking Water to Laying Hens. Food Additives and Contaminants, 8, 65-69. http://dx.doi.org/10.1080/02652039109373956
[19]
Omija, B., Mittema, E.S. and Maitho, T.E. (1994) Oxytetracycline Residue Levels in Chicken Eggs after Oral Administration of Medicated Drinking Water to Laying Hens. Food Additives and Contaminants, 11, 641-647. http://dx.doi.org/10.1080/02652039409374265
[20]
Ji, L.-W., Dong, L.-L., Ji, H., Feng, X.-W., Li, D., Ding, R.-L. and Jiang, S.-X. (2014) Comparative Pharmacokinetics and Bioavailability of Tylosin Tartrate and Tylosin Phosphate after a Single Oral and i.v. Administration in Chickens. Journal of Veterinary Pharmacology and Therapeutics, 37, 312-315. http://dx.doi.org/10.1111/jvp.12092
[21]
Burrows, G.E., Barto, P.B., Martin, B. and Tripp, M.L. (1983) Comparative Pharmacokinetics of Antibiotics in Newborn Calves: Chloramphenical, Lincomycin and Tylosin. American Journal of Veterinary Research, 44, 1053-1057.
[22]
Atef, M., El-Gendi, A.Y.I., Amer, A.M. and Kamel, G.M. (2009) Pharmacokinetic Assessment of Tylosin Concomitantly Administered with Two Anticoccidials; Diclazuril and Halofuginone in Broiler Chickens. Advances in Environmental Biology, 3, 210-218. http://www.insipub.com/aensi/aeb/2009/210-218.pdf
[23]
Atef, M., Youssef, S.A., Atta, A.H. and El-Maaz, A.A. (1991) Disposition of Tylosin in Goats. British Veterinary Journal, 147, 207-215. http://dx.doi.org/10.1016/0007-1935(91)90045-O
[24]
Gingerich, D., Baggot, J. and Kowalski, J. (1977) Erythromycin Antimicrobial Activity and Pharmacokinetics in Cows. Canadian Veterinary Journal, 18, 96-100.
[25]
Locke, D., Bush, M. and Carpenter, J.W. (1982) Pharmacokinetics and Tissue Concentrations of Tylosin in Selected Avian Species. American Journal of Veterinary Research, 43, 1807-1810.
[26]
Cezary, K. and Malgorzata, P. (2006) Evaluation of Bioequivalence of Two Tylosin Formulations after Oral Administration in Broiler Chickens. ANNALES, 3, 25-29.
[27]
Abu-Basha, E.A., Al-Shunnaq, A.F. and Gehring, R. (2012) Comparative Pharmacokinetics and Bioavailability of Two Tylosin Formulations in Chickens after Oral Administration. Journal of the Hellenic Veterinary Medical Society, 63, 159-165.
[28]
Ziv, G. and Sulman, F.G. (1973) Passage of Polymyxins from Serum into Milk in Ewes. American Journal of Veterinary Research, 34, 317-322.
[29]
European Agency for the Evaluation of European Medicines Agency (EMEA) (2002) Committee for Veterinary Medicinal Products (Tylosin) Extension to Eggs; Summary Report (4). The European Agency for the Evaluation of Medicinal Products; London.
[30]
European Agency for the Evaluation of European Medicines Agency (EMEA) (2000) Committee for Veterinary Medicinal Products (Tylosin) Extension to Eggs; Summary Report (4). The European Agency for the Evaluation of Medicinal Products; London. http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits _-_Report/2009/11/WC500015767.pdf
